Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017).
Por:
Salvador F, Treviño B, Chamorro-Tojeiro S, Sánchez-Montalvá A, Herrero-Martínez JM, Rodríguez-Guardado A, Serre-Delcor N, Torrús D, Goikoetxea J, Zubero Z, Velasco M, Sulleiro E, Molina I, López-Vélez R and Pérez-Molina JA
Publicada:
1 may 2019
Ahead of Print:
16 may 2019
Resumen:
Imported strongyloidiasis is increasingly being diagnosed in non-endemic areas. The aim of this study was to describe the epidemiological, clinical and microbiological characteristics of patients with imported strongyloidiasis in Spain.
Filiaciones:
Salvador F:
Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain
Treviño B:
Tropical Medicine and International Health Unit Drassanes-Vall d'Hebron, PROSICS Barcelona, Barcelona, Spain
Chamorro-Tojeiro S:
Ramón y Cajal University Hospital, Madrid, Spain
Sánchez-Montalvá A:
Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain
Herrero-Martínez JM:
Hospital Universitario 12 de Octubre, Madrid, Spain
Rodríguez-Guardado A:
Hospital Universitario Central de Asturias, Oviedo, Spain
Serre-Delcor N:
Tropical Medicine and International Health Unit Drassanes-Vall d'Hebron, PROSICS Barcelona, Barcelona, Spain
:
Hospital General Universitario de Alicante, Alicante, Spain
Goikoetxea J:
Hospital Universitario Cruces, Barakaldo, Spain
Zubero Z:
Hospital de Basurto, Bilbao, Spain
Velasco M:
Hospital Universitario Fundacion Alcorcon, Madrid, Spain
Sulleiro E:
Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain
Molina I:
Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, PROSICS Barcelona, Barcelona, Spain
López-Vélez R:
Ramón y Cajal University Hospital, Madrid, Spain
Pérez-Molina JA:
Ramón y Cajal University Hospital, Madrid, Spain
gold, Green Published, Green Submitted
|